2024-520288-15-00招募中4 期
RAXO trial - A population-based prospective study to evaluate clinical behaviour, resectability and survival in metastatic colorectal cancer patients in Finland
HUS-Yhtymae21 个研究点 分布在 1 个国家目标入组 8,159 人开始时间: 2025年1月24日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 8,159
- 试验地点
- 21
- 主要终点
- Primary objective: • To assess clinical behaviour of metastatic colorectal cancer and overall resectability, postoperative morbidity and outcomes after resection
研究概览
简要总结
Primary objective: • To assess clinical behaviour of metastatic colorectal cancer and overall resectability, postoperative morbidity and outcomes after resection
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 否
入选标准
- •Inclusion criteria
- •Patients with histologically confirmed CRC, who are scheduled to start or are getting first line chemotherapy for metastatic disease
- •Age 18 years
- •Metastatic disease (including locally advanced disease not amenable with surgery and/or (chemo)radiotherapy)
- •Signed written informed consent form (ICF) according to ICH/GCP and the regulatory authorities' approval will be obtained prior to study
- •No informed consent form will be obtained from patients participating in the data collection study obtaining data from hospital records and Finnish cancer registry and other health registries. No blood sampling, nor contacting of patients will be performed.
排除标准
- •No exclusion criteria
结局指标
主要结局
Primary objective: • To assess clinical behaviour of metastatic colorectal cancer and overall resectability, postoperative morbidity and outcomes after resection
Primary objective: • To assess clinical behaviour of metastatic colorectal cancer and overall resectability, postoperative morbidity and outcomes after resection
次要结局
未报告次要终点
研究者
Pia Österlund
Scientific
HUS-Yhtymae
研究点 (21)
Loading locations...
相似试验
招募中
2 期
Phase 2 randomised study of Radspherin® in patients with peritoneal carcinomatosis from colorectal carcinoma after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)2023-508496-37-00Oncoinvent ASA65
招募中
2 期
METIMMOX-2: Oxaliplatin Chemotherapy and Immunotherapy to Patients with the Common pMMR/MSS Type of Large Bowel Cancer Spread to Other OrgansColorectal cancer2022-500027-76-00Akershus University Hospital40
招募中
4 期
Multicentre Phase IV clinical trial to evaluate the efficacy of hyperthermic intraoperative chemotherapy (HIPEC) with Mitomycin-C after complete surgical debulking in patients with peritoneal metastases of colon cancer.2024-512726-28-00Hospital Universitario De Fuenlabrada216
已完成
不适用
Risk of Metachronous Advanced Colorectal Neoplastic Among Individuals With Varying Numbers of Non-Advanced Adenomas Detected During Screening ColonoscopyColorectal AdenomaNCT07302139Fudan University2,955
招募中
3 期
Randomized phase 3 trial comparing FOLFOX to gemcitabine in metastatic first-line in patients with pancreatic adenocarcinoma and non-fit for FOLFIRINOX (GEMFOX)2024-511904-18-00Assistance Publique Hopitaux De Paris400